40 results  1 of 3 

1 The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease
Jin Yu, Han-Sang Baek, Chaiho Jeong, Kwanhoon Jo, Jeongmin Lee, Jeonghoon Ha, Min Hee Kim, Jungmin Lee, Dong-Jun Lim
Endocrinol Metab.2023;38(3):338-346.   Published online 2023 June 9     DOI: http://dx.doi.org/10.3803/EnM.2023.1664
      
2 Metabolite Changes during the Transition from Hyperthyroidism to Euthyroidism in Patients with Graves’ Disease
Ho Yeop Lee, Byeong Chang Sim, Ha Thi Nga, Ji Sun Moon, Jingwen Tian, Nguyen Thi Linh, Sang Hyeon Ju, Dong Wook Choi, Daiki Setoyama, Hyon-Seung Yi
Endocrinol Metab.2022;37(6):891-900.   Published online 2022 December 26     DOI: http://dx.doi.org/10.3803/EnM.2022.1590
      
3 Long-term management of Graves disease: a narrative review
Hyo-Jeong Kim
J Yeungnam Med Sci.2022;40(1):12-22.   Published online 2022 November 4     DOI: http://dx.doi.org/10.12701/jyms.2022.00444
      
4 Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
Min Joo Kim, Sun Wook Cho, Ye An Kim, Hoon Sung Choi, Young Joo Park, Do Joon Park, Bo Youn Cho
Endocrinol Metab.2022;37(3):524-532.   Published online 2022 June 16     DOI: http://dx.doi.org/10.3803/EnM.2022.1418
      
5 Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review
Meihua Jin, Bictdeun Kim, Ahreum Jang, Min Ji Jeon, Young Jun Choi, Yu-Mi Lee, Dong Eun Song, Won Gu Kim
Endocrinol Metab.2022;37(2):312-322.   Published online 2022 April 25     DOI: http://dx.doi.org/10.3803/EnM.2021.1318
      
6 Usefulness of Real-Time Quantitative Microvascular Ultrasonography for Differentiation of Graves’ Disease from Destructive Thyroiditis in Thyrotoxic Patients
Han-Sang Baek, Ji-Yeon Park, Chai-Ho Jeong, Jeonghoon Ha, Moo Il Kang, Dong-Jun Lim
Endocrinol Metab.2022;37(2):323-332.   Published online 2022 April 13     DOI: http://dx.doi.org/10.3803/EnM.2022.1413
      
7 Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
Yoon Young Cho, Bongseong Kim, Dong Wook Shin, Hye Ryoun Jang, Bo-Yeon Kim, Chan-Hee Jung, Jae Hyeon Kim, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
Endocrinol Metab.2022;37(2):281-289.   Published online 2022 April 6     DOI: http://dx.doi.org/10.3803/EnM.2021.1333
      
8 Risk of Diabetes in Patients with Long-Standing Graves’ Disease: A Longitudinal Study
Eyun Song, Min Ji Koo, Eunjin Noh, Soon Young Hwang, Min Jeong Park, Jung A Kim, Eun Roh, Kyung Mook Choi, Sei Hyun Baik, Geum Joon Cho, Hye Jin Yoo
Endocrinol Metab.2021;36(6):1277-1286.   Published online 2021 December 16     DOI: http://dx.doi.org/10.3803/EnM.2021.1251
      
9 Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves’ Disease: A Retrospective Multicenter Study
Jee Hee Yoon, Meihua Jin, Mijin Kim, A Ram Hong, Hee Kyung Kim, Bo Hyun Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Ho-Cheol Kang
Endocrinol Metab.2021;36(6):1268-1276.   Published online 2021 November 26     DOI: http://dx.doi.org/10.3803/EnM.2021.1227
      
10 Antithyroid Drug Treatment in Graves’ Disease
Jae Hoon Chung
Endocrinol Metab.2021;36(3):491-499.   Published online 2021 June 16     DOI: http://dx.doi.org/10.3803/EnM.2021.1070
      
11 Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
Jee Hee Yoon, Min-ho Shin, Hee Nam Kim, Wonsuk Choi, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab.2021;36(3):599-606.   Published online 2021 June 2     DOI: http://dx.doi.org/10.3803/EnM.2021.965
      
12 Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, Eun-Gyoung Hong
Endocrinol Metab.2019;34(3):268-274.   Published online 2019 September 26     DOI: http://dx.doi.org/10.3803/EnM.2019.34.3.268
   
13 Position and size of the sphenoid door jamb in the lateral orbital wall for the orbital decompression
Kang-Jae Shin, Shin-Hyo Lee, Tae-Jun Ha, Hyun Jin Shin, Ki-Seok Koh, Wu-Chul Song, Doo-Jin Paik
Anat Cell Biol.2019;52(3):242-249.   Published online 2019 September 26     DOI: http://dx.doi.org/10.5115/acb.19.101
      
14 A Case of Graves' Disease Accompanied with Acute Hepatitis A Virus Infection
Seong Eun Hong, Jin Woo Choo, Soo Kyung Lim, Seong Jin Lee, Ji Won Park, Sung Eun Kim, Jong Hyeok Kim, Choong Kee Park
Korean J Gastroenterol.2018;71(6):354-358.   Published online 2018 June 27     DOI: http://dx.doi.org/10.4166/kjg.2018.71.6.354
   
15 Genome-Wide Association Studies of Autoimmune Thyroid Diseases, Thyroid Function, and Thyroid Cancer
Yul Hwangbo, Young Joo Park
Endocrinol Metab.2018;33(2):175-184.   Published online 2018 June 21     DOI: http://dx.doi.org/10.3803/EnM.2018.33.2.175
   
16 Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease
Hoon Sung Choi, Won Sang Yoo
Endocrinol Metab.2017;32(2):281-287.   Published online 2017 June 23     DOI: http://dx.doi.org/10.3803/EnM.2017.32.2.281
      
17 Increased Risk of Chronic Spontaneous Urticaria in Patients With Autoimmune Thyroid Diseases: A Nationwide, Population-based Study
Yoon Seob Kim, Kyungdo Han, Ji Hyun Lee, Nack In Kim, Joo Young Roh, Seong Jun Seo, Hae Jun Song, Min-Geol Lee, Jee Ho Choi, Young Min Park
Allergy Asthma Immunol Res.2017;9(4):373-377.   Published online 2017 April 18     DOI: http://dx.doi.org/10.4168/aair.2017.9.4.373
      
18 Recent Advances in Autoimmune Thyroid Diseases
Won Sang Yoo, Hyun Kyung Chung
Endocrinol Metab.2016;31(3):379-385.   Published online 2016 August 26     DOI: http://dx.doi.org/10.3803/EnM.2016.31.3.379
      
19 Cholestyramine Use for Rapid Reversion to Euthyroid States in Patients with Thyrotoxicosis
Jeonghoon Ha, Kwanhoon Jo, Borami Kang, Min-Hee Kim, Dong-Jun Lim
Endocrinol Metab.2016;31(3):476-479.   Published online 2016 July 26     DOI: http://dx.doi.org/10.3803/EnM.2016.31.3.476
      
20 Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
Hyemi Kwon, Won Gu Kim, Eun Kyung Jang, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim
Endocrinol Metab.2016;31(2):300-310.   Published online 2016 April 25     DOI: http://dx.doi.org/10.3803/EnM.2016.31.2.300
   

 1 of 3